Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page
- Check6 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's version metadata. No study content or data appears to have been altered.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s revision was updated from v3.5.3 to v3.5.4, indicating a newer build of the entry. This update seems to be a metadata/version change rather than a modification to study details or visible content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3, reflecting a website/UI release rather than a modification to the study record content.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check101 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check123 days agoChange Detected- Revision label updated from v3.4.1 to v3.4.2 on the page. This is a minor frontend/version change that does not affect study details or eligibility criteria.SummaryDifference0.1%

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.